We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Public Citizen secured an improved settlement for some parents who claim GlaxoSmithKline (GSK) misled them about the effects of antidepressant Paxil in children under the age of 18, the group announced. Read More
Medtronic Inc. said on Tuesday that it would appeal a U.S. district court ruling that the medical device maker is liable for its use of certain stent patents. Read More
Merck is suing Teva Pharmaceutical to block the generic firm’s bid to market generic Singulair tablets, according to a lawsuit filed in federal court last week.
The U.S. Supreme Court will not make a determination on Ranbaxy’s challenge of the validity and enforceability of Pfizer’s main Lipitor patent, the court said.
The U.S. Supreme Court will not make a determination on Ranbaxy’s challenge of the validity and enforceability of Pfizer’s main Lipitor patent, the court said this week.
IMPAX Laboratories has acknowledged the validity and enforceability of a key patent held by Purdue covering its pain treatment OxyContin, according to a settlement agreement reached by both companies.
The reversal of a U.S. district court’s decision that dismissed a legal action brought by Teva Pharmaceutical to launch generic Famvir may have positive implications for generic firms taking moves to avoid at-risk launches, according to legal sources.